Sentynl Therapeutics Receives Great Place To Work® Certification
03 Jun 2024 //
PR NEWSWIRE
Zydus unit acquires global rights to Eiger BioPharma’s Zokinvy
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
03 May 2024 //
PR NEWSWIRE
UK MHRA approves Sentynl ’ Nulibry for injection a first therapy fo MoCD type A
18 Apr 2024 //
PHARMABIZ